Mapping male circumcision for HIV prevention efforts in sub-Saharan Africa by Cork, Michael A. et al.
RESEARCH ARTICLE Open Access
Mapping male circumcision for HIV
prevention efforts in sub-Saharan Africa
Michael A. Cork1, Kate F. Wilson1, Samantha Perkins1, Michael L. Collison1, Aniruddha Deshpande1,
Jeffrey W. Eaton1,2, Lucas Earl1, Emily Haeuser1, Jessica E. Justman3,4, Damaris K. Kinyoki1, Benjamin K. Mayala5,
Jonathan F. Mosser1,6, Christopher J. L. Murray1,6, John N. Nkengasong7, Peter Piot8, Benn Sartorius6,8,
Lauren E. Schaeffer1, Audrey L. Serfes1, Amber Sligar1, Krista M. Steuben1, Frank C. Tanser9,10,11,12,
John D. VanderHeide1, Mingyou Yang1, Njeri Wabiri13, Simon I. Hay1,6† and Laura Dwyer-Lindgren1,6*†
Abstract
Background: HIV remains the largest cause of disease burden among men and women of reproductive age in
sub-Saharan Africa. Voluntary medical male circumcision (VMMC) reduces the risk of female-to-male transmission of
HIV by 50–60%. The World Health Organization (WHO) and Joint United Nations Programme on HIV/AIDS (UNAIDS)
identified 14 priority countries for VMMC campaigns and set a coverage goal of 80% for men ages 15–49. From
2008 to 2017, over 18 million VMMCs were reported in priority countries. Nonetheless, relatively little is known
about local variation in male circumcision (MC) prevalence.
Methods: We analyzed geo-located MC prevalence data from 109 household surveys using a Bayesian geostatistical
modeling framework to estimate adult MC prevalence and the number of circumcised and uncircumcised men aged
15–49 in 38 countries in sub-Saharan Africa at a 5 × 5-km resolution and among first administrative level (typically
provinces or states) and second administrative level (typically districts or counties) units.
Results: We found striking within-country and between-country variation in MC prevalence; most (12 of 14) priority
countries had more than a twofold difference between their first administrative level units with the highest and lowest
estimated prevalence in 2017. Although estimated national MC prevalence increased in all priority countries with the
onset of VMMC campaigns, seven priority countries contained both subnational areas where estimated MC prevalence
increased and areas where estimated MC prevalence decreased after the initiation of VMMC campaigns. In 2017, only
three priority countries (Ethiopia, Kenya, and Tanzania) were likely to have reached the MC coverage target of 80% at
the national level, and no priority country was likely to have reached this goal in all subnational areas.
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Conclusions: Despite MC prevalence increases in all priority countries since the onset of VMMC campaigns in 2008,
MC prevalence remains below the 80% coverage target in most subnational areas and is highly variable. These
mapped results provide an actionable tool for understanding local needs and informing VMMC interventions for
maximum impact in the continued effort towards ending the HIV epidemic in sub-Saharan Africa.
Keywords: Male circumcision, Medical male circumcision, Voluntary medical male circumcision, HIV, HIV prevention,
Intervention, Mapping, Africa, Geospatial, Geostatistics, Spatial statistics
Background
Despite considerable progress made in combating the
HIV epidemic in the past three decades, HIV/AIDS re-
mains the single largest cause of health loss among men
and women of reproductive age in sub-Saharan Africa
[1]. In 2017, an estimated 25.9 million people were living
with HIV in sub-Saharan Africa, with over one million
newly infected in that year [1]. Voluntary medical male
circumcision (VMMC), defined as the complete surgical
removal of the foreskin [2], has emerged in recent years
as an effective intervention to reduce HIV transmission
risk. Typically limited to boys and men ages 10 years
and older, VMMC reduces the risk of female-to-male
transmission of HIV by 50–60% [3–5]. Outside of a clin-
ical trial setting, several long-term assessments have
confirmed VMMC’s protective role in reducing HIV
burden [6, 7], and even demonstrated a rise in effective-
ness as high as 73% [6]. Recent evidence justifies the
VMMC implementation now in progress [8–11], bol-
stered by additional meta-analyses [10, 12]. Moreover,
VMMC is one-time, efficient, safe, cost-effective, and the
only HIV prevention method specifically aimed at het-
erosexual men—a group with historically low HIV test-
ing rates [13]. VMMC provides a unique opportunity to
increase awareness of HIV status among millions of men
and boys who might otherwise forgo HIV testing [14].
Protective effects also extend to partners of circumcised
men; female partners have decreased risks of genital
ulcer disease, cervical cancer, trichomonas infection, and
bacterial vaginosis, among other outcomes [15]. Further,
there is growing evidence that VMMC reduces risk of
HIV transmission among men who have sex with men
(MSM) [16].
As a result of this compelling evidence, the regional
scale-up of VMMC has been immense. The World Health
Organization (WHO) and the Joint United Nations
Programme on HIV/AIDS (UNAIDS) designated 14 prior-
ity countries in southern and eastern Africa with high
national HIV prevalence and low coverage of male
circumcision (MC), as of 2017 consisting of Botswana,
Eswatini, Ethiopia, Kenya, Lesotho, Malawi, Mozambique,
Namibia, Rwanda, South Africa, Tanzania, Uganda,
Zambia, and Zimbabwe [17] (in 2018 South Sudan was in-
cluded, bringing the total priority countries to 15) [18].
Between 2008 and 2017, nearly 18.6 million VMMCs were
reported in priority countries with the support of national
and global programs including the US President’s Emer-
gency Plan for AIDS Relief (PEPFAR) and the Global Fund
to Fight AIDS, Tuberculosis and Malaria [2, 13]. The
WHO estimated that VMMC campaigns had already
averted 230,000 new HIV infections by 2017, with over
one million infections anticipated to be averted by 2030
[2]. An ambitious target was set in 2012 to reach 80% MC
coverage of men ages 15–49 years by 2015, and while
most countries are still working towards meeting this
coverage, new complementary targets focus on 90%
coverage in younger males ages 10–29 [19]. The
WHO maintains a target of 25 million total circumci-
sions by 2020 in priority countries to help achieve
these high rates of MC [20].
Notwithstanding this unprecedented scale-up of
VMMC, there are currently no comprehensive estimates
of MC prevalence in sub-Saharan Africa that report over
multiple years and at a subnational level. UNAIDS pre-
sents national-level estimates compiled from population-
based surveys in their annual global updates, but these
are limited to the select countries and years in which
surveys were administered [20]. While there is evidence
of substantial subnational variation of MC coverage [21–
24], past studies that estimate MC prevalence in multiple
countries in Africa often report only at the national level
[25], and those that do report subnational MC preva-
lence include only a subset of available survey data and
are confined to individual countries and few years [21,
22]. In the majority of existing estimates and in our
current analysis, MC prevalence encompasses not only
MC performed by VMMC, but also traditional circumci-
sion, which is influenced by values and beliefs that differ
across cultural, religious, and ethnic identities [24, 26,
27]. While traditional circumcision is often non-medical,
taking place in a non-clinical setting by a traditional pro-
vider with no formal medical training [27], it can also in-
clude medical MC carried out in a clinical setting by a
trained and supervised service provider [28]. Traditional
circumcisions that occur in a medical setting may have a
similar procedure to that of VMMC, but in our analysis,
VMMC refers only to the intervention strategy adopted
in 2008. Due to this variation in practice, evidence that
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traditional circumcision is protective against HIV is
mixed [18, 29, 30]. Nonetheless, yearly estimates of MC
prevalence can provide valuable information on the un-
met needs of men amenable to VMMC who have not
undergone any form of MC. Further, tracking MC
prevalence over multiple years provides insight into how
quickly VMMC efforts are raising MC coverage, and al-
lows for additional precision in MC estimates by lever-
aging strength across different survey years and in
neighboring countries.
The absence of comprehensive subnational MC esti-
mates is troubling given the demonstrated acute subna-
tional variation in HIV prevalence across sub-Saharan
Africa [31] and the growing evidence that MC preva-
lence may play a role in driving the spatial distribution
of the HIV epidemic [21]. Various studies have empha-
sized that HIV prevention services that focus on the
local epidemiological context are able to achieve greater
impact than uniformly distributed services [32–35], but
the lack of robust subnational information on MC cover-
age precludes many countries from adopting this ap-
proach [36]. To track VMMC scale-up and progress
towards coverage targets, the WHO reports the number
of VMMCs performed by country and year [2]. VMMC
monitoring and report systems are often reported in par-
allel to or embedded within national health information
systems and data processing often involves multiple
partners, which can present a challenge to interpretation
of absolute numbers given it can increase the likelihood
of errors, especially as it relates to MC coverage changes
at a subnational level [37]. In addition, the absolute
number of newly circumcised men does not translate to
MC prevalence in a specified age group, making it diffi-
cult to assess progress towards coverage goals. To best
inform HIV prevention efforts and describe progress to-
wards coverage targets, local MC coverage estimates
should be produced based on data sources independent
of reported VMMCs, should cover all locations, should
support tracking changes in MC coverage over time, and
should capture patterns of the number of circumcised
and uncircumcised men over time and space.
In this analysis, we provide the first comprehensive,
annual estimates of MC coverage and numbers of cir-
cumcised and uncircumcised men ages 15–49 residing
in 38 countries in sub-Saharan Africa at local (5 × 5 km)
and subnational (first and second administrative levels)
spatial resolutions from 2000 to 2017. We do not restrict
our study to the 14 VMMC priority countries given the
availability of data in 38 countries in sub-Saharan Africa
and the shortage of current estimates of MC coverage
across the continent. Further, there is evidence that
some countries or subnational areas may later become
relevant to policymakers; for example, in 2018, South
Sudan initiated a pilot VMMC program [18].
Nonetheless, we focus the majority of our analysis on
the priority countries selected for VMMC campaigns be-
cause of their present relevance to decision-makers and
stakeholders in allocating resources to VMMC services.
In these countries, we examine the local distribution of
MC prevalence and uncircumcised men in 2017 and de-
scribe changes in MC prevalence and the number of cir-
cumcised men at subnational levels in relation to the
onset of VMMC campaigns. Finally, we assess countries’
progress towards the 80% MC coverage target at na-
tional and subnational levels.
Methods
Input data
We compiled a dataset of 38,747 geo-referenced obser-
vations from 109 household surveys conducted between
2000 and 2017 in 38 countries in sub-Saharan Africa as
defined by the Global Burden of Disease (GBD) study
[11]. We assembled this dataset through a review of
major survey series (Demographic and Health Survey
[DHS], AIDS Indicator Survey [AIS], Multiple Indicator
Cluster Survey [MICS], Core Welfare Indicators Ques-
tionnaire Survey [CWIQ], Population-based HIV Impact
Assessment Survey [PHIA]) and surveys tagged with the
“circumcision” keyword in the Global Health Data Ex-
change [38]. We included all surveys that asked men
about their circumcision status, were sampled from the
general population, and contained subnational geograph-
ical information (Supplementary Table 1 in Add-
itional file 1). We excluded countries in sub-Saharan
Africa with no data availability from our analysis. We
also excluded the island nation of São Tomé and Prín-
cipe, despite having one data source with low sample
size, due to evidence that its MC coverage patterns were
substantially lower than the regional trends, which
would break our implicit model assumption that areas
that are close in space and time borrow information on
MC prevalence (Supplementary Table 2). Survey data
were not required to distinguish between medical and
traditional male circumcision, and in the few surveys
that included both, MC prevalence was derived from
summing across both variables. Survey data were origin-
ally in two forms: survey microdata (i.e., individual-level
survey responses) or survey reports (Supplementary
Table 1). For surveys with available microdata, we ex-
tracted variables related to age, MC status, location, and
survey weights. After subsetting the data to ages 15–49
years and excluding observations with missing informa-
tion on any of these variables (4.0% of all observations),
we aggregated the data by calculating the survey-
weighted MC prevalence at the most precise spatial
resolution available. The ideal spatial resolution was a
latitude and longitude point that represented the loca-
tion of the survey cluster (point-level data), but when
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not available, we geo-located survey microdata to the
smallest geographical areal unit (termed a polygon), typ-
ically representing an administrative unit. In instances
where data were matched to a polygon rather than spe-
cific GPS coordinates, these data were “resampled” pro-
portional to the underlying population in the areal unit
to mimic point data. The population data used for this
analysis were obtained from WorldPop [39]. The
methods for sampling point locations from areas associ-
ated with areal data are consistent with previous studies
using model-based geostatistics [31, 40–43]. Weighting
by sample size, 70.7% of all data were associated with
GPS coordinates, while the remaining data were associ-
ated with polygons and resampled using this approach.
Several survey reports presented MC estimates for age
groups other than 15–49 years (five sources representing
1.4% of the total effective sample size; Supplementary
Table 3 in Additional file 1). In order to incorporate data
from these reports, we used a cross-walking model—an
approach for linking disparate data sources (in this case
data sources reporting for different age groups)—that
used existing microdata and a linear regression to con-
vert the prevalence in the reported age range to the
standard 15–49 age range. The age cross-walk is consist-
ent with the method previously used in the geospatial
modeling of HIV [31]; this process calculated a new
sample size that reflects our confidence in the estimate
of MC prevalence as a function of the uncertainty in our
linear model and the original sample size. The distribu-
tion of geo-located MC prevalence data is shown in Sup-
plementary Fig. 1, and a list of sources is also located in
Supplementary Table 1 in Additional file 1. We excluded
three data sources in Nigeria because lower coverage
contradicted several independent DHS surveys in the
same country, and there was evidence that at least one
of the reports had been previously flagged for data valid-
ation issues. The excluded data and the reasoning for
their exclusion can be found in Supplementary Table 2.
Additional methodological details on data identification
and processing are also presented in section 2 in
Additional file 1.
Data analysis
We modeled MC prevalence using a Bayesian spatially
and temporally explicit generalized linear mixed effects
model developed previously for an analysis of HIV
prevalence and updated for this analysis (Supplementary
Fig. 2 in Additional file 1) [31]. Due to computational
constraints and to allow for regional differences in the
temporal and spatial autocorrelation in MC prevalence,
we fit separate models for four geographically contigu-
ous regions in sub-Saharan Africa adapted from the Glo-
bal Burden of Diseases, Injuries, and Risk Factors study
(Supplementary Fig. 3 in Additional file 1) [1]. We
excluded countries in sub-Saharan Africa with no data
availability, with the exception of São Tomé and Prín-
cipe, which was excluded despite having one data source
due to evidence that its MC patterns were substantially
different from the regional trends. Within our Bayesian
geostatistical model, MC coverage was modeled as bino-
mial count data with a logit link function and the linear
model included an intercept, a fixed effect on year, a
country-level random effect, an autocorrelated spatio-
temporal random effect, and an uncorrelated error term
(nugget effect). Unlike similar past analyses [40–43], we
did not use covariates for this analysis given that predict-
ive covariates such as ethnicity, culture, or religion were
not available at our model’s spatial and temporal reso-
lution. Due to the absence of viable covariates and the
limited availability of survey data in the most recent
year, extrapolation of our estimates to later years in the
study period was often informed by the regional time
trend provided by the fixed effect on year. After fitting
the model, we generated 1000 draws of MC prevalence
from the approximated joint posterior distribution at
each 5 × 5-km grid cell across each model region and
year in the study period. We calculated point estimates
for each grid cell as the mean of these draws, and we
designated the 95% uncertainty intervals as the 2.5th and
97.5th percentiles of these draws.
In addition to estimates of MC prevalence on a 5 × 5-
km spatial grid, we produced estimates of MC preva-
lence for first and second administrative level units. We
constructed these estimates by calculating population-
weighted averages of MC prevalence for each grid cell or
fraction of a grid cell within a given first or second ad-
ministrative level unit as defined by the Database of Glo-
bal Administrative Areas (GADM) [44]. We list the
names and the number of designated first and second
administrative level units in each country in Supplemen-
tary Table 4 in Additional file 1. Furthermore, we de-
rived estimates of the number of circumcised and
uncircumcised men in each administrative unit by multi-
plying estimated MC prevalence or uncircumcised
prevalence, respectively, in each grid cell by the corre-
sponding WorldPop population estimates of men ages
15–49 and aggregating to administrative units. Finally,
we calculated the posterior probability of exceeding 80%
MC prevalence in 2017 at the 5 × 5-km level and among
administrative units as the percentage of draws from the
approximated posterior distribution in which MC preva-
lence was 80% or greater. Throughout our analysis, we
qualify statements as statistically significant if the poster-
ior probability of that statement exceeds 95%. All models
were fitted using an integrated nested Laplace approxi-
mation in the R-INLA package, version 3.3.2 [45, 46].
We performed both in-sample and out-of-sample
model validation using a spatiotemporal fivefold cross-
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validation strategy. Out-of-sample validation metrics for
MC coverage indicate good model fit with spatial strati-
fication at the second administrative level (Supplemen-
tary Table 5 in Additional file 1), including mean error
(0.6 percentage-points), root-mean-square error (8.7
percentage-points), and 95% coverage of predictive inter-
vals (97.0%). Additional results and details on data prep-
aration, modeling, estimation, and validation can be
found in Additional file 1.
Results
Regional patterns of MC prevalence
Across sub-Saharan Africa, there were stark regional
contrasts in estimated MC prevalence, with high levels
of MC prevalence in western and central sub-Saharan
Africa, low levels of MC prevalence in southern sub-
Saharan Africa, and variable levels of MC prevalence in
eastern sub-Saharan Africa (Figs. 1 and 2, Supplemen-
tary Figs. 4–6). Estimated MC prevalence in most coun-
tries in western and central sub-Saharan Africa was
largely uniformly high; estimated coverage was greater
than 85% in > 95% of second administrative level units
in these countries from 2000 to 2017. Conversely, esti-
mated MC prevalence in southern and eastern sub-
Saharan African countries with lower levels of MC over-
all was heterogeneous in space and time. The 14 priority
countries identified by WHO/UNAIDS for VMMC were
among the group with lower coverage: 13 of these coun-
tries (excluding Ethiopia) were among the 15 countries
with the lowest estimated national MC prevalence at the
start of VMMC campaigns in 2008 (along with Burundi
and Guinea-Bissau).
Geographic variations of MC prevalence and the number
of uncircumcised men in 2017
Within priority countries, estimated MC prevalence var-
ied substantially among first and second administrative
level units. In Kenya, with a high estimated national
prevalence of 90.8% (95% uncertainty interval, 86.8–
93.8%), MC prevalence varied at the first administrative
Fig. 1 Estimated male circumcision prevalence, adult men ages 15–49 years, 2017. Male circumcision prevalence among adult men ages 15–49
years in 2017 at the country level (a), first administrative unit level (b), second administrative unit level (c), and 5 × 5-km grid-cell level (d). Maps
reflect administrative boundaries, land cover, lakes, and population. Grid cells with fewer than ten people per 1 × 1-km [39] and classified as
“barren or sparsely vegetated” [47] are colored in dark gray. Countries in light gray were not included in the analysis. Outlined by a thick black
border are priority countries for VMMC campaigns in southern and eastern Africa, as identified by the WHO and UNAIDS
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level from 99.6% (98.8–99.9%) in the Makueni county to
40.9% (24.4–57.8%) in the Turkana county in 2017. In
Uganda, with a more moderate national prevalence of
45.6% (38.6–52.1%), MC prevalence varied at the first
administrative level from 87.4% (79.2–93.5%) in the Kas-
ese district to 10.0% (4.4–18.4%) in the Pader district in
2017. These considerable subnational differences in preva-
lence were less apparent in low-prevalence settings, but
still notable; for example, in Zimbabwe (national
prevalence, 15.3% [11.8–19.3%]), MC prevalence varied at
the first administrative level from 28.3% (16.6–41.4%) in
the Bulawayo province to 9.8% (6.1–14.5%) in the Ma-
shonaland Central province in 2017. There was a more
than twofold difference in MC prevalence between the
first administrative level units with the highest and lowest
estimated prevalence in most (12 of 14; barring Lesotho
and Eswatini) priority countries in 2017. This heterogen-
eity in MC prevalence increased at the second
Fig. 2 Mean, lower, and upper bounds of estimated male circumcision, ages 15–49, 2017. MC prevalence among males ages 15–49 in 2017 at
the first administrative unit level (a–c), second administrative unit level (d–f), and 5 × 5-km grid-cell level (g–i). Mean estimates and lower and
upper bounds of the 95% uncertainty intervals are shown in the left, middle, and right columns, respectively. Maps reflect administrative
boundaries, land cover, lakes, and population. Grid cells with fewer than ten people per 1 × 1-km [39] and classified as “barren or sparsely
vegetated” [47] are colored in dark gray. Countries in light gray were not included in the analysis
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administrative level, where nearly half (6 of 14) of the
VMMC priority countries had more than a fivefold differ-
ence between their second administrative level units with
the lowest and highest estimated prevalence in 2017
(Fig. 3).
We estimated that a large proportion of uncircumcised
men were concentrated in a small number of geographical
areas. At the country level in 2017, roughly half (49.8%) of
the estimated 34.5 (32.9–36.1) million uncircumcised men
in sub-Saharan Africa resided in South Africa, Uganda,
Zambia, and Zimbabwe, compared to 13.6% of all men in
sub-Saharan Africa aged 15–49 residing in those countries.
The majority (30.5 [29.2–32.0] million; 88.5% [86.2–90.3%])
of uncircumcised men in sub-Saharan Africa were concen-
trated in the 14 priority countries. Furthermore, within pri-
ority countries in 2017, more than half (50.3%) of all
uncircumcised men were concentrated in just 123 (9.1%)
second administrative level units, compared to 29.2% of all
men aged 15–49 in priority countries residing in those ad-
ministrative units (Fig. 4). We also observed this heteroge-
neous spatial distribution of uncircumcised men within
each priority country. In 12 of 14 countries (excluding
Eswatini and Rwanda), more than half of the country’s esti-
mated uncircumcised men resided in only 30% or fewer
Fig. 3 Range of estimated male circumcision prevalence at the second administrative level, 2017. Estimated range of male circumcision prevalence for
each second administrative level unit in 2017 by country. Each point represents the estimated prevalence of a single second administrative level unit
within a country in 2017, and the vertical bars indicate the prevalence of the highest and lowest second administrative level units in 2017 by country.
Color indicates whether or not the country was a priority country for VMMC campaigns, as identified by the WHO and UNAIDS
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second administrative level units. In eight countries, more
than half of the country’s uncircumcised men lived in 20%
or fewer second administrative level units.
Time trends in MC prevalence and the number of
circumcised men
Estimated MC prevalence changed considerably over
time, and the temporal trends were marked by the onset
of large-scale VMMC campaigns in priority countries
from 2008 onwards (Fig. 5, Supplementary Fig. 7). From
2000 to 2008, prior to the VMMC campaigns’ inception,
the estimated mean national MC prevalence stagnated
in all priority countries; the model does not predict a
statistically significant (posterior probability > 95%)
increase or decrease in any country’s national MC preva-
lence over this period. At subnational levels over the
same time period, we estimated an increase in MC
prevalence in 60.1% (37.1–80.1%) and 58.7% (43.7–
71.6%) of first and second administrative level units, re-
spectively. However, among those administrative units
with an estimated increase in MC prevalence, the me-
dian estimated increase was slight—2.0 and 2.2
percentage-points in first and second administrative level
units, respectively. Furthermore, only 0.7% of our esti-
mated increases at all first administrative level units
were statistically significant (posterior probability > 95%),
indicating high uncertainty in MC temporal trends from
2000 to 2008.
In contrast, and corresponding with the onset of the
VMMC campaigns, the estimated number of circum-
cised men and MC coverage increased in priority coun-
tries from 2008 to 2017. The total number of
circumcised men in priority countries rose by 21.5
(19.9–23.0) million in this period, from 42.5 (41.8–43.2)
million in 2008 to 64.0 (62.5–65.3) million in 2017. Over
this same period, national MC coverage increased in all
priority countries, and this increase was statistically sig-
nificant (posterior probability > 95%) in all countries bar-
ring Ethiopia. Within priority countries, however, the
magnitude of increase varied; for example, estimated
MC prevalence rose by 1.0 (− 1.7, 3.7) percentage-points
in Ethiopia and 22.9 (15.2–31.3) percentage-points in
Lesotho. At subnational levels, we estimated an increase
in MC prevalence in 91.9% (86.0–95.8%) and 84.7%
(78.1–90.0%) of all first and second administrative level
units, respectively, in priority countries. Among those
administrative units with an estimated increase in MC
prevalence, the median estimated increase was 15.0
percentage-points and 12.2 percentage-points in first
and second administrative level units, respectively. These
Fig. 4 Estimated number of uncircumcised adult men at the second administrative level, 2017. Number of uncircumcised men ages 15–49 years
in 2017 at the second administrative unit level. Maps reflect administrative boundaries, land cover, lakes, and population. Grid cells with fewer
than ten people per 1 × 1-km [39] and classified as “barren or sparsely vegetated” [47] are colored in dark gray. Countries in light gray were not
included in the analysis. Outlined by a thick black border are priority countries for VMMC campaigns in southern and eastern Africa, as identified
by the WHO and UNAIDS
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estimated increases were also more certain; 65.1% of the
estimated increases in first administrative level units
were statistically significant (posterior probability > 95%).
While there was a generalized surge in estimated MC
prevalence that coincided with the onset of VMMC ef-
forts from 2008 onwards, these broad trends mask large
subnational disparities. Three of the 14 priority coun-
tries—Tanzania, Mozambique, and Ethiopia—contained
areas where estimated MC prevalence increased as well
as areas where estimated MC prevalence decreased
among first administrative level units; this was true for
seven priority countries at the second administrative
level. While we estimated a decrease in 121 (8.9%) of
second administrative level units in priority countries
after the onset of VMMC campaigns in 2008, the magni-
tude of these declines was small (mean across units, 2.6
[0.4–4.9] percentage-points) and the impacted areas gen-
erally had high coverage in 2008 (mean across units,
90.5% [89.3–91.6]) and therefore still had high coverage
in 2017 (mean across units, 88.0% [85.8–89.9]). In cer-
tain areas, these differences were substantial. For ex-
ample, in Mozambique, where the national estimated
MC prevalence rose by 7.6 (1.4–13.3) percentage-points
from 2008 to 2017, the difference in coverage at the sec-
ond administrative level ranged from an estimated -23.0
(-45.2, -3.5) percentage-point change in the Muidumbe
district (from 88.9% [76.7–96.1%] to 65.9% [42.5–84.2%])
to a 28.6 (5.8–49.5) percentage-point change in the
Xai-Xai district (from 27.6% [16.1–41.0%] to 56.2%
[35.5–74.3%]) over the same time period. Even in
countries where we estimated an increase in MC
coverage for all first and second administrative level
units, this heterogeneity persisted. In Uganda, where
the estimated national MC coverage increased by
22.9 (15.2–31.3) percentage-points from 2008 to
2017, change in estimated MC prevalence varied
from a 3.6 (-4.8, 13.4) percentage-point change in
Bukonzo county (from 89.8% [79.8–95.7%] to 93.4%
Fig. 5 Estimated change in male circumcision prevalence, adult men age 15–49, in 14 priority countries. Absolute change at the country level in
male circumcision prevalence among adults age 15–49 between 2000 and 2008 (a) and between 2008 and 2017 (b). Absolute change at the
second administrative unit level in male circumcision prevalence between 2000 and 2008 (c) and between 2008 and 2017 (d). Maps reflect
administrative boundaries, land cover, lakes, and population. Grid cells with fewer than ten people per 1 × 1-km [39] and classified as “barren or
sparsely vegetated” [47] are colored in dark gray. Countries in light gray were not included in the analysis. Outlined by a thick black border are
priority countries for VMMC campaigns in southern and eastern Africa, as identified by the WHO and UNAIDS
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[86.2–97.4%]) to a 40.8 (15.3–61.7) percentage-point
change in Masindi county (from 19.6% [8.3–37.0%]
to 58.8% [37.8–78.9%]).
Progress towards MC coverage target
Despite these increases, we find strong evidence in only
three priority countries of having met the goal of 80%
MC coverage by 2017 and do not find strong evidence
in any country of reaching the 80% coverage target in
the collection of administrative units targeted for
VMMC. Figure 6 depicts the posterior probability that a
given area exceeded the 80% MC coverage target in
2017; high posterior probability indicates substantial evi-
dence that an area met this target, while low posterior
probability indicates substantial evidence the area did
not meet this target. There was strong evidence that
Ethiopia, Kenya, and Tanzania reached the aspirational
80% coverage goal in 2017 (posterior probability > 99.9%)
and strong evidence that all other priority countries failed
to meet this goal (posterior probability < 0.01%). In some
countries, national coverage estimates are less relevant
given that VMMC implementation is limited to a regional
focus; for example, VMMC implementation in Ethiopia is
focused exclusively on the Gambela Region [18]. At sub-
national levels, the evidence for 80% MC coverage is more
mixed, even in countries with strong evidence (posterior
probably > 95%) to have reached the national coverage
goal. In Ethiopia, 10 (12.7%) of its second administrative
level units are unlikely (posterior probability < 5%) to have
achieved the coverage target. Conversely, in Mozambique,
where there is strong evidence that national MC preva-
lence did not meet the coverage goal, there is nonetheless
strong evidence (posterior probability > 95%) that 33
(25.6%) districts did accomplish this goal in 2017.
Discussion
This study is a comprehensive and spatially detailed
quantification of MC prevalence and the number of
Fig. 6 Posterior probability of exceeding 80% male circumcision coverage, adult men ages 15–49, 2017. Posterior probability of exceeding the
80% male circumcision prevalence target among adult men ages 15–49 in 2017 at the country level (a), first administrative unit level (b), second
administrative unit level (c), and 5 × 5-km grid-cell level (d). Maps reflect administrative boundaries, land cover, lakes, and population. Grid cells
with fewer than ten people per 1 × 1-km [39] and classified as “barren or sparsely vegetated” [47] are colored in dark gray. Countries in light gray
were not included in the analysis. Outlined by a thick black border are priority countries for VMMC campaigns in southern and eastern Africa, as
identified by the WHO and UNAIDS
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circumcised and uncircumcised men living in 38 coun-
tries in sub-Saharan Africa from 2000 to 2017. Our esti-
mates highlight meaningful increases in underlying MC
coverage in VMMC priority countries but also reveal
persistent differences in MC prevalence and the distribu-
tion of uncircumcised men across and within those
countries. Addressing this geospatial variation is critical
for the continued scale-up of VMMC and optimization
of MC as a preventative tool to help mitigate the HIV
epidemic.
These subnational estimates provide an actionable
framework for locally tailored VMMC interventions that
acknowledge local epidemiological contexts to reduce
HIV transmission. Considering the geographical vari-
ation in the HIV epidemic, UNAIDS has repeatedly
called for renewed research efforts into the use of spatial
analysis in epidemiology and health services research to
identify populations in greatest need of prevention ser-
vices [20, 48]. In accordance with this notion, recent
modeling studies have demonstrated that a focused ap-
proach to interventions that identify people and loca-
tions with low access to HIV prevention strategies like
VMMC that are also at high risk of HIV infection is
more cost-effective and efficient than a uniform ap-
proach in preventing new HIV infections [33–35]. This
strategy has already been employed in sub-Saharan Af-
rica: from 2010 to 2014, South Africa allocated provin-
cial resources for VMMC based on population size and
epidemiology, which included HIV and MC prevalence
[34, 49]. In Tanzania, starting in 2012, geographic infor-
mation systems were an effective tool for prioritizing
VMMC needs in underserved rural communities [50].
This level of geographical precision, however, is not
widespread; the WHO and UNAIDS emphasize that
most countries lack sufficiently robust data to prioritize
provinces or districts according to the potential impact
and cost-effectiveness of MC [36]. This analysis provides
the spatial precision to fill this gap in data and can be
used to identify geographically granular areas where low
uptake of MC might be one factor driving local HIV
transmission [21]. This, in combination with similarly
detailed estimates of HIV prevalence [31], can bolster
VMMC programs by highlighting areas where MC
coverage is low and HIV burden is high, enabling
decision-makers to investigate areas with low coverage
and devise locally tailored strategies that continue a
trend towards precise and high-impact VMMC inter-
ventions [22].
This analysis highlights significant challenges in the
scale-up of VMMC and gaps in reaching 80% coverage
of MC in priority countries. As opposed to the northern
and western regions of sub-Saharan Africa where esti-
mated MC prevalence levels were consistently high,
likely due to traditional circumcision practices [51], our
estimates highlight spatial and temporal disparities in
MC coverage in southern and eastern Africa—especially
in high priority countries selected for VMMC scale-up.
While all priority countries demonstrated gains in MC
coverage since the onset of VMMC national campaigns
in 2008, our estimates indicate this improvement has
not been uniform between and within countries. More-
over, priority countries Kenya, Tanzania, Mozambique,
and Ethiopia all contained areas where estimated MC
prevalence decreased from 2008 to 2017, possibly as a
result of migration and men aging in and out of the 15–
49 age group. The WHO recommends prioritizing
VMMC in areas where HIV incidence exceeds the na-
tional average, and countries targeting VMMC in groups
of men at high risk for HIV or STI infection may explain
some local differences in MC coverage [19]. Nonethe-
less, these disparities are also concurrent with reported
implementation delays due to challenges such as finan-
cial and human resource limitations, as well as geo-
graphical heterogeneity in the desirability and demand
for VMMC [16, 37]. Recent studies concluded that 50 to
87% of men in sub-Saharan Africa find VMMC an ac-
ceptable form of HIV prevention, highlighting a poten-
tial barrier to implementation and uptake as well as a
potential source of local differences in MC status [15,
38]. Additional reported barriers include socio-economic
factors such as anxiety over the cost of the procedure
and a concern for a loss of wages for working-class men,
especially in the informal employment sector [52, 53].
The estimated geographical differences may also reflect
locations with limited access to VMMC facilities and
HIV preventative care [39]. Despite progress, most prior-
ity countries were far from achieving 80% coverage in
2017, and none are likely to have achieved this goal in
all subnational areas. While the established goal to per-
form 25 million VMMCs in priority countries by 2020
[20] is laudable, these targets are not sufficient to ensure
uniformly high MC coverage at local levels. We estimate
that in 2017, there were still 31.6 million uncircumcised
men residing in priority countries in sub-Saharan Africa,
many of whom were concentrated in a few subnational
locations. This analysis complements existing reports of
the absolute number of circumcisions performed and
provides a framework for tracking progress towards 80%
coverage by highlighting areas with high numbers of un-
circumcised men and low subnational MC coverage.
While our study focuses on estimates of subnational
patterns in MC coverage, VMMC is only one compo-
nent of a comprehensive HIV prevention package. Add-
itionally, because VMMC provides only partial
protection against HIV transmission, care is required to
ensure there is no sexual risk compensation among cir-
cumcised men—a concern that has been previously
raised [54], though other studies have found no evidence
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of risk compensation [55]. VMMC is projected to avert
more than one million new HIV infections by 2030 [2],
but VMMC alone is not sufficient to achieve the 2020
global target of fewer than 500,000 new HIV infections
annually [20]. In order to be most effective in reducing
HIV transmission, VMMC must be combined with other
HIV prevention services. VMMC is one of five HIV pre-
vention pillars outlined by UNAIDS, alongside combin-
ation prevention for adolescent girls, young women, and
their male partners; combination prevention programs
for all key populations; comprehensive national condom
programs; and rapid introduction of pre-exposure
prophylaxis (PrEP) [20]. Countries have already demon-
strated the impact of VMMC in this consolidated frame-
work: in Kenya, the dual scale-up of antiretroviral
therapy and VMMC was associated with a substantial
decline in HIV incidence, and VMMC was suggested to
have a direct protective effect [56]. Additionally, contin-
ued close integration of VMMC with HIV testing ser-
vices is crucial given the spatial distribution of the HIV
epidemic. Nearly a decade ago, VMMC priority coun-
tries were chosen based on low national MC prevalence
and high HIV prevalence, and in 2017, a substantial
number of areas with low MC coverage still overlapped
with areas where HIV prevalence was high [31]. By iden-
tifying areas of high HIV prevalence and low MC cover-
age and continued linkage to HIV testing services,
VMMC campaigns could help increase awareness of
HIV status among millions of men and boys living in
high-prevalence areas and improve access to HIV treat-
ment. Furthermore, additional geospatial mapping of
factors that drive the spatial distribution of the HIV epi-
demic and are components of a comprehensive preven-
tion package such as ART treatment availability, access
to PrEP, and condom use could be the next step for re-
ducing HIV burden.
Limitations
This study is subject to several limitations. First, our
analysis is limited by the availability of the underlying
data. For our research, we constructed a large database
of geo-located MC prevalence data; still, there are gaps
in data coverage in both time and space (Supplementary
Figs. 1 and 7 in Additional file 1). For example, across
VMMC priority countries, the most recent survey used
in our analysis ranged from 2013 to 2017. As a result, in
priority countries with continued VMMC scale-up but
without recent data, we likely underestimate MC preva-
lence in recent years. Further, over 4 million VMMCs
were performed in priority countries in 2018 [18], but
currently, there are too few available surveys to reliably
extend our analysis to include MC prevalence in 2018.
In many VMMC priority countries, however, there are
surveys that are either recently completed or currently
in the field that will improve our estimates in the future.
Second, there are several factors that could impact the
quality of the data used in our analysis. Survey data are
subject to social desirability bias as well as non-response
bias, and the response rate can vary across countries and
years. We applied a complete-case analysis that did not
adjust for non-response bias; future research could as-
sess the impact of the response rate on estimates of MC
prevalence. Our results also rely on self-reported cir-
cumcision status that does not distinguish between trad-
itional and medical male circumcision. Past research has
found that self-reported MC status may be subject to
misreporting errors due to confusion between medical
and traditional circumcision practices [57]. Traditional
circumcision is often performed in a non-clinical setting,
and evidence of its protective effects against HIV trans-
mission is mixed, largely due to discrepancies in defining
MC when traditionally performed [27, 29, 30, 58]. Our
current analysis provides valuable information on the
unmet needs of men who can be reached by VMMC
given they have not undergone any form of MC. In the
future, distinguishing between non-medical and medical
MC would provide a more accurate description of how
MC translates to reduced HIV transmission risk. Fur-
ther, the geographical precision of our data is subject to
some error. Most surveys that collect GPS coordinates
perform random displacement to safeguard respondent
confidentiality; for example, in the Demographic and
Health Surveys (DHS), survey clusters are displaced by
as much as 2-km for urban clusters, 5-km for rural clus-
ters, and 10-km in 1% of rural clusters [59]. While this
can affect a geostatistical model’s predictive power, past
research determined that even with GPS displacement,
model estimates at a 5 × 5-km resolution are still rela-
tively accurate [60]. Third, while we have attempted to
quantify uncertainty in our estimates from various
sources, some sources of uncertainty could not be in-
cluded in the model, such as uncertainty associated with
the population estimates. Population estimates from
WorldPop are also subject to error, particularly in
sparsely populated areas, which may affect the accuracy
of our predictions for the number of circumcised and
uncircumcised men, especially at fine geographical de-
tail. While WorldPop estimates include censuses data as
inputs to their modeling framework [61], depending on
timing and data accessibility, estimates may differ from
the underlying census measures and may not utilize the
most recent census or the most detailed tabulations.
Fourth, we use GADM shapefiles to define administra-
tive subdivisions, and differences in administrative divi-
sions between GADM and individual country’s
designation of administrative areas may affect the accur-
acy of results, especially in our estimates of the number
of circumcised and uncircumcised men. Fifth, we were
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unable to include covariates in our model because none
of the variables we expect to be most predictive—such
as ethnicity, culture, or religion—were available at our
spatial or temporal resolution. Future covariates that
correlate with ethnicity, culture, or religion would help
improve our model predictions in locations and time pe-
riods with sparse data coverage. Sixth, our modeling
strategy “borrows strength” across space and time to in-
form estimates in locations and time periods with very
small sample sizes and to interpolate in locations and
time periods with no directly observed MC prevalence
data. While we believe this is generally appropriate, there
may be specific locations and times where this method-
ology breaks down; for example, abrupt differences in
MC prevalence in neighboring locations or time periods
are unlikely to be reflected in our estimates unless they
are directly observed in the underlying MC data and if
those data have substantial sample sizes. Finally, our es-
timates of MC convey only one component of a compre-
hensive HIV preventative package and only one of many
potential drivers of the spatial distribution of the HIV
epidemic. Policymakers must take care not to inter-
pret areas of low MC coverage as definite areas of
high HIV burden and vice versa; there are many
other factors that contribute to the underlying HIV
burden at a local scale.
Future directions
There is ample opportunity to expand this analysis in
the future. In addition to including more contemporan-
eous surveys as they become available, our analysis could
also leverage spatially located non-national data sources
or data from other research studies. In addition, our
current analysis focuses only on one defined age group:
males ages 15–49. Past research has shown important
variation in the magnitude of impact and cost-
effectiveness of VMMC scale-up among different age
groups [46] and has indicated that focusing on younger
age groups may be the most cost-effective and impactful
VMMC intervention [48]. In line with this research, the
WHO has called for new coverage targets to be set by
age strata as opposed to uniformly set over the entire
15–49 age range [24]. New global targets aligned with
the UNAIDS fast track goals aim for 90% MC coverage
in men ages 10–29 [19]. While our current analysis fo-
cuses on ages 15–49 due to the availability of data and
alignment with the original fast track goals, in future
analyses, progress towards coverage targets should be
monitored by multiple age strata at subnational levels,
including younger adolescents. Finally, future analyses
that combine estimates of local MC prevalence with in-
formation on local HIV incidence could further identify
high-risk areas that would benefit from VMMC inter-
vention. At present, the only estimates of HIV burden at
the same geographic precision report HIV prevalence,
an imperfect measure of the risk of acquiring HIV. In
the future, independently constructed estimates of local
HIV incidence combined with maps of MC prevalence
could provide compelling evidence to identify priority
administrative areas for VMMC campaigns.
Conclusion
In this analysis, we present geographically granular esti-
mates of male circumcision prevalence that can inform
efforts to address local HIV prevention needs, especially
in high-risk hotspots of HIV transmission in sub-
Saharan Africa. While all 14 countries identified as pri-
orities for VMMC by the WHO experienced national in-
creases in MC between 2008 and 2017, half experienced
decreases in MC prevalence in some of their subnational
areas and none are predicted to meet the 80% MC
coverage target across all subnational areas. Our analysis
clearly demonstrates that more funding, resources, and
accountability are needed in order to reach the proposed
coverage goals at all subnational levels by 2020, and our
estimates can aid policymakers in resource prioritization
decisions. VMMC remains one of the most cost-effective
and impactful HIV interventions available, and empha-
sizing small-scale gaps in coverage and the impact of
VMMC services is crucial to maintaining progress to-
wards an end to the HIV/AIDS epidemic.
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